Paris - Delayed Quote EUR
Genfit S.A. (GNFT.PA)
3.9200
-0.0620
(-1.56%)
At close: June 4 at 5:35:09 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
15,549
15,549
-55,429
-72,638
99,915
Investing Cash Flow
-1,039
-1,039
2,234
-46,266
-3,377
Financing Cash Flow
-10,570
-10,570
-5,098
-3,786
-8,916
End Cash Position
81,788
81,788
77,789
136,001
258,756
Capital Expenditure
-979
-979
-2,488
--
-537
Issuance of Capital Stock
61
61
0
5
27,972
Issuance of Debt
0
0
89
0
15,270
Repayment of Debt
-10,283
-10,283
-4,694
-1,748
-50,323
Free Cash Flow
14,570
14,570
-57,917
-72,638
99,378
12/31/2021 - 12/19/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DBV.PA DBV Technologies S.A.
1.3980
-0.71%
PHXM.PA PHAXIAM Therapeutics S.A.
0.2000
-0.50%
ALSEN.PA Sensorion SA
0.4000
+8.11%
VLA.PA Valneva SE
2.7560
-0.43%
POXEL.PA Poxel S.A.
0.6640
-6.87%
ABNX.PA ABIONYX Pharma SA
1.2700
-3.05%
ALCOX.PA Nicox S.A.
0.2270
-0.66%
ALBPS.PA Biophytis S.A.
0.1310
+0.31%
OSE.PA OSE Immunotherapeutics SA
6.25
+1.38%
SIGHT.PA GenSight Biologics S.A.
0.2045
-5.76%